Abstract
Although SeO32− ions have been loaded onto calcium phosphate to treat a wide range of cancers, the quest to promote bone tissue regeneration is still ongoing. Curcumin (cur), an herbal extraction, can selectively inhibit tumor cells and promote osteogenesis. In this study, SeO32− ions were co-precipitated in biomimetic calcium phosphate (Se@BioCaP), and modified curcumin prodrug (mcur) was adsorbed on diverse Se@BioCaP surfaces (mcur-Se@BioCaP-Ads). Co-precipitation yielded Se@BioCaP with a significantly higher Se content and exhibited a tailorable micro-/nanostructure. The favorable pH-responsive release of Se and mcur from mcur-Se@BioCaP-Ads showed a synergistic anticancer efficiency in OS cells, enhancing OS cell inhibition more than a single dose of them, which might be associated with ROS production in OS cells. In addition, increased alkaline phosphatase activity and calcium nodule formation in MC3T3-E1 pre-osteoblasts were also verified. These results suggest this novel mcur-Se@BioCaP-Ads has promising and widespread potential in OS treatments.
Original language | English |
---|---|
Article number | 327 |
Pages (from-to) | 1-12 |
Number of pages | 12 |
Journal | Journal of Functional Biomaterials |
Volume | 15 |
Issue number | 11 |
Early online date | 3 Nov 2024 |
DOIs | |
Publication status | Published - Nov 2024 |
Bibliographical note
This article belongs to the Special Issue: Mesoporous Nanomaterials for Bone Tissue Engineering.Publisher Copyright:
© 2024 by the authors.
Keywords
- biomimetic calcium phosphate
- curcumin
- osteogenesis
- osteosarcoma
- ROS
- selenium